Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow culturesLEMOLI, R. M; GULATI, S. C.Stem cells (Dayton, OH). 1993, Vol 11, Num 5, pp 435-444, issn 1066-5099Article

Dendritic cells: specialized antigen presenting cellsDI NICOLA, M; LEMOLI, R. M.Haematologica (Roma). 2000, Vol 85, Num 2, pp 202-207, issn 0390-6078Article

In vitro cytotoxicity of VP-16-213 and nitrogen mustard : agonistic on tumor cells but not on normal human bone marrow progenitorsLEMOLI, R. M; GULATI, S. C.Experimental hematology. 1990, Vol 18, Num 9, pp 1008-1012, issn 0301-472X, 5 p.Article

Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor β3 (TGF-β3) on human primitive hematopoietic progenitor cellsLEMOLI, R. M; FOGLI, M; FORTUNA, A et al.Haematologica (Roma). 1995, Vol 80, Num 1, pp 5-12, issn 0390-6078Article

Negative selection of autologous peripheral blood stem cellsLEMOLI, R. M; CURTI, A; TURA, S et al.Baillière's best practice & research. Clinical haematology. 1999, Vol 12, Num 1-2, pp 57-69, issn 1521-6926Article

Stem cell mobilization and collection in patients with liver cirrhosisLORENZINI, S; ISIDORI, A; FORBES, S. J et al.Alimentary pharmacology & therapeutics. 2008, Vol 27, Num 10, pp 932-939, issn 0269-2813, 8 p.Article

Rapid induction of CD40 on a subset of granulocyte colony-stimulating factor-mobilized CD34⁺ blood cells identifies myeloid committed progenitors and permits selection of nonimmunogenic CD40^- progenitor cellsRONDELLI, D; LEMOLI, R. M; RATTA, M et al.Blood. 1999, Vol 94, Num 7, pp 2293-2300, issn 0006-4971Article

Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cellsVISANI, G; LEMOLI, R. M; RIZZI, S et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 5, pp 467-472, issn 0268-3369Article

Ex vivo expansion of hematopoietic cells and their clinical useAGLIETTA, M; BERTOLINI, F; CARLO-STELLA, C et al.Haematologica - Journal of hematology. 1998, Vol 83, Num 9, pp 824-848Article

Immunotoxins containing saporin linked to different CD2 monoclonal antibodies : in vitro evaluationTAZZARI, P. L; BOLOGNESI, A; DE TOTERO, D et al.British journal of haematology. 1994, Vol 86, Num 1, pp 97-105, issn 0007-1048Article

In vitro growth of myeloma cellsVISANI, G; LEMOLI, R. M; TOSI, P et al.European journal of haematology. Supplementum. 1989, Vol 51, pp 43-46, issn 0902-4506, 4 p.Conference Paper

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationHÜBEL, K; FRESEN, M. M; LANZA, F et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 8, pp 1046-1050, issn 0268-3369, 5 p.Article

Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myelomaCAVO, M; TERRAGNA, C; TURA, S et al.Blood. 2000, Vol 96, Num 1, pp 355-357, issn 0006-4971Article

Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy : a retrospective comparison of short-term outcome with bone marrow transplantationLEMOLI, R. M; BANDINI, G; TASSI, C et al.Haematologica - Journal of hematology. 1998, Vol 83, Num 1, pp 48-55Article

Peripheral blood mobilization of hematopoietic stem cells : Cytokine-mediated regulation of adhesive interactions within the hematopoietic microenvironmentSANTUCCI, M. A; LEMOLI, R. M; TURA, S et al.Acta haematologica. 1997, Vol 97, Num 1-2, pp 90-96, issn 0001-5792Article

Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cellsLEMOLI, R. M; FOGLI, M; FORTUNA, A et al.British journal of haematology. 1995, Vol 91, Num 2, pp 319-326, issn 0007-1048Article

Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugsTAFURI, A; LEMOLI, R. M; CHEN, R et al.Leukemia. 1994, Vol 8, Num 5, pp 749-757, issn 0887-6924Article

FLAG (fludarabine + cytosine arabinoside +-G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia : a case reportVISANI, G; TOSI, P; ZINZANI, P. L et al.British journal of haematology. 1994, Vol 86, Num 2, pp 394-396, issn 0007-1048Article

Interleukin-11 stimulates the proliferation of human hematopoietic CD34⁺ and CD34⁺CD33^-DR^- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factorLEMOLI, R. M; FOGLI, M; FORTUNA, A et al.Experimental hematology. 1993, Vol 21, Num 13, pp 1668-1672, issn 0301-472XArticle

TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitroLEMOLI, R. M; STRIFE, A; CLARKSON, B. D et al.Experimental hematology. 1992, Vol 20, Num 11, pp 1252-1256, issn 0301-472XArticle

Normal myeloid progenitors (CFU-GM) in multiple myeloma: a preliminary study in view of autologous BMTLEMOLI, R. M; VISANI, G; GOBBI, M et al.Bone marrow transplantation (Basingstoke). 1989, Vol 4, Num 4, pp 373-377, issn 0268-3369Article

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapyLEMOLI, R. M; MARTINELLI, G; TURA, S et al.Blood. 2000, Vol 95, Num 7, pp 2234-2239, issn 0006-4971Article

Selection and transplantation of autologous CD34⁺ B-lineage negative cells in advanced-phase multiple myeloma patients : a pilot studyLEMOLI, R. M; MARTINELLI, G; RONDELLI, D et al.British journal of haematology. 1999, Vol 107, Num 2, pp 419-428, issn 0007-1048Article

Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsRONDELLI, D; RASPADORI, D; LEMOLI, R. M et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 7, pp 631-637, issn 0268-3369Article

Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34⁺ cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF)CATANI, L; GUGLIOTTA, L; CAMPANINI, E et al.British journal of haematology. 1998, Vol 100, Num 1, pp 207-218, issn 0007-1048Article